Use of R191, potent and selective IRAK1/4 kinase inhibitor, in treatment of hematologic malignanciesV. Markovtsov, C. Lamagna,M. Chan, S. Yi,C. Young, R. Forances, S. Siu, S. Braselmann, H. Li,R. Singh,G. Park,E. Masuda,V. Taylor,D. G. PayanEUROPEAN JOURNAL OF CANCER（2016）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
